Sai Life Sciences Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Million)
Sai Life Sciences Ltd · Outcome · 06 Nov 2026, 4:18 am
Sai Life Sciences Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Million) ■ Revenue: 6,586 (+22.5% YoY | +18.8% QoQ) ■ EBITDA: 1,864 (+27.8% YoY | +25.9% QoQ) ■ EBITDA Margin (%): 28.3 (+117 bps YoY | +160 bps QoQ) ■ PAT: 983 (+17.3% YoY | +34.2% QoQ) ■ EPS (INR): 4.58 (+16.5% YoY | +33.9% QoQ)
Original exchange filing (PDF)
More announcements from Sai Life Sciences Ltd
- Upgradation in the Credit Rating by India Rating & Research Pvt. Ltd. · 14 Nov 2026
- Transcripts of Earnings call organized on 06th November 2026 · 12 Nov 2026
- Monitoring Agency Report for the Quarter ended 30th September 2026 · 12 Nov 2026
- Audio Recording of Earnings call for Q-2 FY 2026-27 · 06 Nov 2026
- Investor Presentation on Q-2 FY 2026-27 Financial Results · 06 Nov 2026
- Press Release on Unaudited Financial Results for the Second Quarter and Half Year Ended 30th September 2026. · 06 Nov 2026
- Allotment of 1,08,005 Equity having Face Value of Rs.1/- against the options exercised in accordance with the Companies ESOP Plans · 06 Nov 2026
- Sai Life Sciences Limited has informed the Exchange regarding Allotment of 108005 Shares. · 06 Nov 2026
